Acute stroke: we have the treatments and we have the evidence--we need to use them.

Acute stroke: we have the treatments and we have the evidence--we need to use them. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Acute stroke: we have the treatments and we have the evidence--we need to use them. Abstract Text:

Terence J Quinn,Jesse Dawson,Kennedy R Lees,Terence J Quinn,Jesse Dawson,Kennedy R Lees,

Despite huge global burden, stroke disease has traditionally received little attention in the general medical press. We review a series of four acute stroke research articles published in a themed issue of the Lancet. Claiborne-Johnston and coworkers presented a scoring system to stratify risk of stroke following transient ischaemic attack. Chalela and colleagues demonstrated that magnetic resonance imaging is superior to computed tomography in detecting acute ischaemic stroke and that fears of missing intracranial haemorrhage are unfounded. The SITS-MOST (Safe Implementation of Thrombolysis in Stroke - Monitoring Study) group reported positive experience of translating acute stroke thrombolysis trials into routine clinical practice in Europe, and the PROSIT (Project on Stroke Services in Italy) group studied acute effects of admission to a dedicated stroke unit. The message from all of these reports is that evidence-based, successful management of acute stroke is possible, and that investment in health infrastructure and changing mind sets of health practitioners to improve stroke care will deliver benefits.

Acute stroke: we have the treatments and we have the evidence--we need to use them. Publishing Authors By Initials

TJ Quinn,J Dawson,KR Lees,TJ Quinn,J Dawson,KR Lees,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Acute stroke: we have the treatments and we have the evidence--we need to use them. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Critical care (London, England)

VOLUME: 11

Page Numbers: 124

Journal Abbreviation:

ISSN: 1466-609X

DAY: 16

MONTH: 01

YEAR: 2007

Acute stroke: we have the treatments and we have the evidence--we need to use them. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9801902

Acute stroke: we have the treatments and we have the evidence--we need to use them. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Acute stroke: we have the treatments and we have the evidence--we need to use them. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Acute stroke: we have the treatments and we have the evidence--we need to use them.

AFFILIATION: Gardiner Institute of Cardiovascular and Medical Sciences, Western Infirmary, Dumbarton Road, Glasgow G11 6NT, UK. Tjq1t@clinmed.gla.ac.uk

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Crit Care

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Acute stroke: we have the treatments and we have the evidence--we need to use them Related Publications

• A new method of applying the screen test for inter-ocular muscle balance.
• A statistical and clinical review of 107 cases of ectopic gestation.
• Acute stroke: we have the treatments and we have the evidence--we need to use them.
• Advances in emerging therapies 2007.
• Balancing conformational and oxidative kinetic traps during the folding of bovine pancreatic trypsin inhibitor (BPTI) with glutathione and glutathione disulfide.
• DIAGNOSIS OF DIPLOPIA.
• Effects of the Occupational Safety and Health Administration's control of hazardous energy (lockout/tagout) standard on rates of machinery-related fatal occupational injury.
• FoxO3a preferentially induces p27(Kip1) expression while impairing muscle precursor cell-cycle progression.
• Immunologic studies of subjects with asthma exposed to formaldehyde and urea-formaldehyde foam insulation (UFFI) off products.
• Issues pertaining to the critiques of the SAINT-I Trial.
• Life and death decisions by the E2F transcription factors.
• Modern concepts of instinctive behaviour.
• Parkinson's disease with Onuf's nucleus involvement mimicking multiple system atrophy.
• Prediction and perinatal outcomes of fetal growth restriction.
• Prevention of atherosclerosis progression in asymptomatic healthy elderly.
• Punding in Parkinson's disease.
• Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology.
• RECTAL NARCOSIS IN OPHTHALMIC SURGERY.
• Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults.
• SYNTHESIS OF UNSATURATED FATTY ACIDS IN THE SLIME MOLD PHYSARUM POLYCEPHALUM AND THE ZOOFLAGELLATES LEISHMANIA TARENTOLAE, TRYPANOSOMA LEWISI, AND CRITHIDIA SP.: A COMPARATIVE STUDY.
• Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues.
• THE USE OF UNIT CELLS IN THE LISTER MORTON OPHTHALMOSCOPE.
• The effects of intravenous hyperalimentation on plasma proteins in severe hypercholesterolemia [proceedings].
• The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
• The teaching of venereology.
• Time spent at home poststroke: "home-time" a meaningful and robust outcome measure for stroke trials.
• Tuberculosis among medical and academic students.
• Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's 250th birthday.
• WITHDRAWN: Institutional versus at-home long term care for functionally dependent older people.
• catena-Poly[[bis(nitrato-kappa(2)O,O')copper(II)]-mu-propane-1,3-diylbis(diphenylphosphine oxide)-kappa(2)O:O'].